NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
17.06
Dollar change
-2.10
Percentage change
-10.96
%
Index- P/E- EPS (ttm)-14.82 Insider Own- Shs Outstand2.71M Perf Week-19.22%
Market Cap46.23M Forward P/E- EPS next Y-1.15 Insider Trans- Shs Float2.38M Perf Month10.38%
Enterprise Value40.03M PEG- EPS next Q-0.17 Inst Own2.58% Short Float5.80% Perf Quarter112.19%
Income-20.88M P/S- EPS this Y73.09% Inst Trans0.61% Short Ratio0.57 Perf Half Y322.28%
Sales0.00M P/B8.07 EPS next Y67.42% ROA-137.74% Short Interest0.14M Perf YTD363.59%
Book/sh2.11 P/C7.36 EPS next 5Y- ROE-235.05% 52W High38.25 -55.40% Perf Year91.59%
Cash/sh2.32 P/FCF- EPS past 3/5Y42.48% 48.95% ROIC-364.17% 52W Low2.70 531.85% Perf 3Y-67.19%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility13.41% 18.25% Perf 5Y-93.22%
Dividend TTM- EV/Sales- EPS Y/Y TTM11.88% Oper. Margin- ATR (14)3.50 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.95 Sales Y/Y TTM- Profit Margin- RSI (14)46.50 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.96 EPS Q/Q-11.07% SMA20-18.47% Beta0.70 Target Price35.50
Payout- Debt/Eq0.22 Sales Q/Q- SMA5018.86% Rel Volume1.35 Prev Close19.16
Employees7 LT Debt/Eq0.00 EarningsMay 14 BMO SMA200125.90% Avg Volume244.08K Price17.06
IPOJun 08, 2018 Option/ShortNo / Yes EPS/Sales Surpr.-443.08% 0.00% Trades Volume329,839 Change-10.96%
Jun-27-25 04:30PM
04:30PM
Jun-26-25 07:30AM
Jun-18-25 09:19AM
Jun-17-25 08:00AM
07:00AM Loading…
Jun-13-25 07:00AM
Jun-10-25 08:00AM
Jun-03-25 07:50AM
May-30-25 07:00AM
May-29-25 07:30AM
May-28-25 08:00AM
May-21-25 08:00AM
May-20-25 08:00AM
07:30AM
May-19-25 07:30AM
07:30AM Loading…
May-16-25 07:30AM
May-12-25 08:00AM
May-05-25 07:08AM
Apr-24-25 07:00AM
Apr-22-25 07:00AM
Apr-18-25 04:00PM
Apr-14-25 07:30AM
Apr-10-25 07:30AM
Apr-03-25 07:00AM
Apr-01-25 02:00AM
Mar-31-25 07:00AM
Mar-30-25 07:00PM
Mar-28-25 09:15AM
Mar-27-25 07:00AM
Mar-26-25 07:00AM
08:09AM Loading…
Mar-20-25 08:09AM
07:30AM
Mar-17-25 11:33AM
Mar-07-25 03:00PM
Feb-28-25 11:30AM
Feb-26-25 07:30AM
Feb-18-25 07:30AM
Feb-11-25 07:30AM
Feb-10-25 07:30AM
Feb-06-25 07:30AM
Feb-04-25 08:00AM
07:03AM
Jan-17-25 07:30AM
Jan-14-25 08:30AM
Jan-07-25 08:30AM
Dec-20-24 07:30PM
09:15AM
Dec-13-24 07:00PM
Dec-10-24 07:30AM
Dec-05-24 07:30AM
Nov-25-24 07:00AM
Oct-29-24 07:30AM
Oct-28-24 11:10AM
Oct-23-24 09:30AM
Oct-22-24 07:00AM
Oct-21-24 11:55AM
07:00AM
05:30AM
Oct-15-24 06:00AM
Oct-07-24 08:40AM
Sep-27-24 08:06PM
Sep-25-24 09:20AM
Sep-13-24 04:00PM
Sep-09-24 07:30AM
Sep-06-24 07:30PM
Aug-30-24 10:30AM
07:30AM
Aug-23-24 07:30PM
Aug-15-24 06:00AM
Aug-12-24 07:30AM
Aug-09-24 04:00PM
10:51AM
07:30AM
Jul-25-24 09:20AM
Jul-23-24 03:34PM
10:29AM
Jul-04-24 08:00AM
Jun-28-24 05:00PM
07:30AM
Jun-27-24 07:30AM
Jun-13-24 07:30AM
Jun-04-24 07:30AM
Jun-02-24 03:42PM
May-31-24 07:30AM
May-28-24 08:00AM
May-24-24 05:15PM
May-20-24 10:53AM
May-16-24 08:00AM
May-07-24 08:30AM
Apr-30-24 08:33AM
Apr-25-24 07:47AM
Apr-22-24 08:00AM
Apr-17-24 08:00AM
Apr-15-24 08:00AM
Apr-07-24 10:55PM
Apr-01-24 10:00PM
Mar-27-24 08:00AM
Mar-11-24 08:00AM
Mar-05-24 08:00AM
Feb-28-24 08:00AM
Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.